Sarana Meditama Metropolitan Stock Fundamentals
| SAME Stock | IDR 250.00 8.00 3.10% |
Sarana Meditama Metropolitan fundamentals help investors to digest information that contributes to Sarana Meditama's financial success or failures. It also enables traders to predict the movement of Sarana Stock. The fundamental analysis module provides a way to measure Sarana Meditama's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sarana Meditama stock.
Sarana |
Sarana Meditama Metropolitan Company Return On Equity Analysis
Sarana Meditama's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Sarana Meditama Return On Equity | -0.0035 |
Most of Sarana Meditama's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sarana Meditama Metropolitan is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Sarana Meditama Metropolitan has a Return On Equity of -0.0035. This is 99.99% lower than that of the Health Care Providers & Services sector and 99.75% lower than that of the Health Care industry. The return on equity for all Indonesia stocks is 98.87% lower than that of the firm.
Sarana Meditama Metr Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sarana Meditama's current stock value. Our valuation model uses many indicators to compare Sarana Meditama value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sarana Meditama competition to find correlations between indicators driving Sarana Meditama's intrinsic value. More Info.Sarana Meditama Metropolitan is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sarana Meditama's earnings, one of the primary drivers of an investment's value.Sarana Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sarana Meditama's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sarana Meditama could also be used in its relative valuation, which is a method of valuing Sarana Meditama by comparing valuation metrics of similar companies.Sarana Meditama is currently under evaluation in return on equity category among its peers.
Sarana Fundamentals
| Return On Equity | -0.0035 | |||
| Return On Asset | 0.0015 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 5.14 T | |||
| Shares Outstanding | 17.13 B | |||
| Shares Owned By Insiders | 76.36 % | |||
| Shares Owned By Institutions | 0.09 % | |||
| Price To Earning | 177.12 X | |||
| Price To Book | 1.32 X | |||
| Price To Sales | 3.87 X | |||
| Revenue | 1.27 T | |||
| Gross Profit | 518.68 B | |||
| EBITDA | 259.08 B | |||
| Net Income | 138.55 B | |||
| Cash And Equivalents | 470 B | |||
| Cash Per Share | 21.36 X | |||
| Total Debt | 20.94 B | |||
| Debt To Equity | 75.20 % | |||
| Current Ratio | 3.87 X | |||
| Book Value Per Share | 208.00 X | |||
| Cash Flow From Operations | 253.74 B | |||
| Earnings Per Share | 1.88 X | |||
| Target Price | 730.0 | |||
| Number Of Employees | 2.44 K | |||
| Beta | 0.71 | |||
| Market Capitalization | 5.31 T | |||
| Total Asset | 4.95 T | |||
| Net Asset | 4.95 T |
About Sarana Meditama Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sarana Meditama Metropolitan's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sarana Meditama using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sarana Meditama Metropolitan based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.PT Sarana Meditama Metropolitan Tbk, together with its subsidiaries, engages in the management of hospitals in Indonesia. PT Sarana Meditama Metropolitan Tbk is a subsidiary of PT Omni Health Care. Sarana Meditama is traded on Jakarta Stock Exchange in Indonesia.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Sarana Stock
Sarana Meditama financial ratios help investors to determine whether Sarana Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sarana with respect to the benefits of owning Sarana Meditama security.